Patient characteristics
| Patient characteristics | Number | Per cent |
|---|---|---|
| Age | ||
| Median | 67 | |
| Range | 33–85 | |
| Sex | ||
| Male | 50 | 45.9 |
| Female | 59 | 54.1 |
| Smoking status | ||
| Never | 59 | 54.1 |
| Former/current | 50 | 45.9 |
| Histology | ||
| Adenocarcinoma | 101 | 92.7 |
| Squamous cell carcinoma | 8 | 7.3 |
| Mutational status | ||
| EGFR | 62 | 56.9 |
| ALK | 5 | 4.6 |
| Wild | 42 | 38.5 |
| Pretreatment line | ||
| First | 61 | 56.0 |
| Second | 24 | 22.0 |
| Third or further | 24 | 22.0 |
| Tumour size (mm) | ||
| Mean | 34.6 | |
| Range | 10–89 | |
ALK, anaplastic lymphoma kinase; EGFR, epidermal growth factor receptor.